Aspects of anticoagulation in children

British Journal of Haematology

Volumn 150, Issue 3, 2010, Pages 259-277

  Payne, Jeanette H ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

anticoagulation; children; heparin; thrombosis; warfarin

Indexed keywords

ACENOCOUMAROL; ALCOHOL; ALPHA 2 MACROGLOBULIN; ANTITHROMBIN; ARGATROBAN; BLOOD CLOTTING FACTOR 10A; CYTOCHROME P450 2C9; DABIGATRAN; DALTEPARIN; DANAPAROID; ENOXAPARIN; FONDAPARINUX; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; PROTAMINE; REVIPARIN; RIVAROXABAN; THROMBIN; TINZAPARIN; VITAMIN K GROUP; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; BLEEDING; BOLUS INJECTION; BRAIN HEMORRHAGE; CHILD; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; GROUPS BY AGE; HEMATOTHORAX; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INJECTION SITE BLEEDING; INJECTION SITE CONTUSION; INJECTION SITE INDURATION; LOW DRUG DOSE; MORBIDITY; MORTALITY; NONHUMAN; OSTEOPOROSIS; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; RETROPERITONEAL HEMORRHAGE; REVIEW; TERATOGENICITY; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT DURATION; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; HEPARIN; HUMANS; INFANT, NEWBORN; RECURRENCE; THROMBOSIS; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 77954567215     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08225.x     Document Type: Review

References (128)

1. Albisetti, M., Schmugge, M., Haas, R., Eckhardt, B.P., Bauersfeld, U., Baenziger, O. Hug, M.I. (2005) Arterial thromboembolic complications in critically ill children. Journal of Critical Care, 20, 296 300.
2. Andrew, M. (1992) Anticoagulation and thrombolysis in children. Texas Heart Institute Journal, 19, 168 177.
3. Andrew, M., Ofosu, F., Schmidt, B., Brooker, L., Hirsh, J. Buchanan, M.R. (1988) Heparin clearance and ex vivo recovery in newborn piglets and adult pigs. Thrombosis Research, 52, 517 527.
4. Andrew, M., David, M., Adams, M., Ali, K., Anderson, R., Barnard, D., Bernstein, M., Brisson, L., Cairney, B., DeSai, D., Grant, R., Israels, S., Jardine, L., Luke, B., Massicotte, P. Silva, M. (1994a) Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood, 83, 1251 1257.
5. Andrew, M., Marzinotto, V., Massicotte, P., Blanchette, V., Ginsberg, J., Brill-Edwards, P., Burrows, P., Benson, L., Williams, W., David, M., Poon, A. Sparling, K. (1994b) Heparin therapy in pediatric patients: a prospective cohort study. Pediatric Research, 35, 78 83. (Pubitemid 24004639)
6. Andrew, M., Marzinotto, V., Brooker, L.A., Adams, M., Ginsberg, J., Freedom, R. Williams, W. (1994c) Oral anticoagulation therapy in pediatric patients: a prospective study. Thrombosis and Haemostasis, 71, 265 269. (Pubitemid 24083732)
7. Avioli, L.V. (1975) Heparin-induced osteopenia: an appraisal. Advances in Experimental Medicine and Biology, 52, 375 387.
8. Baglin, T., Barrowcliffe, T.W., Cohen, A. Greaves, M. (2006) Guidelines on the use and monitoring of heparin. British Journal of Haematology, 133, 19 34.
9. Barnes, C., Newall, F., Ignjatovic, V., Wong, P., Cameron, F., Jones, G. Monagle, P. (2005) Reduced bone density in children on long-term warfarin. Pediatric Research, 57, 578 581.
10. Bauman, M.E., Black, K.L., Massicotte, M.P., Bauman, M.L., Kuhle, S., Howlett-Clyne, S., Cembrowski, G.S. Bajzar, L. (2008) Accuracy of the CoaguChek XS for point-of-care international normalised ratio (INR) measurement in children requiring warfarin. Thrombosis and Haemostasis, 99, 1097 1103.
11. Biss, T.T., Brandao, L.R., Kahr, W.H., Chan, A.K. Williams, S. (2008) Clinical features and outcome of pulmonary embolism in children. British Journal of Haematology, 142, 808 818.
12. Bontadelli, J., Moeller, A., Schmugge, M., Schraner, T., Kretschmar, O., Bauersfeld, U., Bernet-Buettiker, V. Albisetti, M. (2007) Enoxaparin therapy for arterial thrombosis in infants with congenital heart disease. Intensive Care Medicine, 33, 1978 1984.
13. Bradbury, M.J., Taylor, G., Short, P. Williams, M.D. (2008) A comparative study of anticoagulant control in patients on long-term warfarin using home and hospital monitoring of the international normalised ratio. Archives of Disease in Childhood, 93, 303 306.
14. Brandjes, D.P., Buller, H.R., Heijboer, H., Huisman, M.V., de Rijk, M., Jagt, H. ten Cate, J.W. (1997) Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet, 349, 759 762.
15. Bucciarelli, P., Rosendaal, F.R., Tripodi, A., Mannucci, P.M., De Stefano, V., Palareti, G., Finazzi, G., Baudo, F. Quintavalla, R. (1999) Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arteriosclerosis,Thrombosis and Vascular Biology, 19, 1026 1033.
16. Buck, J.R., Connors, R.H., Coon, W.W., Weintraub, W.H., Wesley, J.R. Coran, A.G. (1981) Pulmonary embolism in children. Journal of Pediatric Surgery, 16, 385 391.
17. Burk, C.D., Miller, L., Handler, S.D. Cohen, A.R. (1992) Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics, 89, 691 695.
18. Chan, A.K., Black, L., Ing, C., Brandao, L.R. Williams, S. (2008) Utility of aPTT in monitoring unfractionated heparin in children. Thrombosis Research, 122, 135 136.
19. Chiu, H.M., Hirsh, J., Yung, W.L., Regoeczi, E. Gent, M. (1977) Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis. Blood, 49, 171 184.
20. Couturaud, F., Julian, J.A. Kearon, C. (2001) Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis. Thrombosis and Haemostasis, 86, 980 984.
21. Cyr, C., Michon, B., Pettersen, G., David, M. Brossard, J. (2006) Venous thromboembolism after severe injury in children. Acta Haematologica, 115, 198 200.
22. Deitcher, S.R., Topoulos, A.P., Bartholomew, J.R. Kichuk-Chrisant, M.R. (2002) Lepirudin anticoagulation for heparin-induced thrombocytopenia. Journal of Pediatrics, 140, 264 266.
23. Dix, D., Andrew, M., Marzinotto, V., Charpentier, K., Bridge, S., Monagle, P., deVeber, G., Leaker, M., Chan, A.K. Massicotte, M.P. (2000) The use of low molecular weight heparin in pediatric patients: a prospective cohort study. Journal of Pediatrics, 136, 439 445.
24. Eichinger, S., Minar, E., Bialonczyk, C., Hirschl, M., Quehenberger, P., Schneider, B., Weltermann, A., Wagner, O. Kyrle, P.A. (2003) D-dimer levels and risk of recurrent venous thromboembolism. Journal of the American Medical Association, 290, 1071 1074. (Pubitemid 37430448)
25. Filippi, L., Palermo, L., Pezzati, M., Dani, C., Matteini, M., De Cristofaro, M.T. Rubaltelli, F.F. (2004) Paradoxical embolism in a preterm infant. Developmental Medicine and Child Neurology, 46, 713 716.
26. Finazzi, G., Brancaccio, V., Moia, M., Ciaverella, N., Mazzucconi, M.G., Schinco, P.C., Ruggeri, M., Pogliani, E.M., Gamba, G., Rossi, E., Baudo, F., Manotti, C., D'Angelo, A., Palareti, G., De Stefano, V., Berrettini, M. Barbui, T. (1996) Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. American Journal of Medicine, 100, 530 536.
27. Franzeck, U.K., Schalch, I. Bollinger, A. (1997) On the relationship between changes in the deep veins evaluated by duplex sonography and the postthrombotic syndrome 12 years after deep vein thrombosis. Thrombosis and Haemostasis, 77, 1109 1112.
28. Garcia, D., Libby, E. Crowther, M.A. (2010) The new oral anticoagulants. Blood, 115, 15 20.
29. Gibson, B.E.S., Chalmers, E.A., Bolton-Maggs, P., Henderson, D.J. Lynn, R. (2003) Thromboembolism in childhood: a prospective two year BPSU study in the United Kingdom. February 2001-February 2003. Thrombosis and Haemostasis, 1 (Suppl. 1 OC422.
30. Goldenberg, N.A., Knapp-Clevenger, R. Manco-Johnson, M.J. (2004) Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. New England Journal of Medicine, 351, 1081 1088.
31. Goldenberg, N.A., Knapp-Clevenger, R., Hays, T. Manco-Johnson, M.J. (2005) Lemierre's and Lemierre's-like syndromes in children: survival and thromboembolic outcomes. Pediatrics, 116, e543 e548.
32. Goldenberg, N.A., Durham, J.D., Knapp-Clevenger, R. Manco-Johnson, M.J. (2007) A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children. Blood, 110, 45 53.
33. Greaves, M. (2002) Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thrombosis and Haemostasis, 87, 163 164.
34. Greaves, M. (2009) Pathogenesis and management of antiphospholipid syndrome. Thrombosis Research, 123 (Suppl. 2 S4 S9.
35. Hausdorf, G., Bentele, K. Hellwege, H.H. (1982) [Nephrocalcinosis following candida-septicemia and heparin-induced osteoporosis in an infant (author's transl)]. Monatsschrift für Kinderheilkunde, 130, 168 170.
36. Hausler, M., Hubner, D., Delhaas, T. Muhler, E.G. (2001) Long term complications of inferior vena cava thrombosis. Archives of Disease in Childhood, 85, 228 233.
37. Hofmann, S., Knoefler, R., Lorenz, N., Siegert, G., Wendisch, J., Mueller, D., Taut-Sack, H., Dinger, J. Kabus, M. (2001) Clinical experiences with low-molecular weight heparins in pediatric patients. Thrombosis Research, 103, 345 353.
38. Ignjatovic, V., Furmedge, J., Newall, F., Chan, A., Berry, L., Fong, C., Cheng, K. Monagle, P. (2006) Age-related differences in heparin response. Thrombosis and Haemostasis, 118, 741 745.
39. Jackson, P.C. Morgan, J.M. (2008) Perioperative thromboprophylaxis in children: development of a guideline for management. Paediatric Anaesthesia, 18, 478 487.
40. Kearon, C., Kahn, S.R., Agnelli, G., Goldhaber, S., Raskob, G.E. Comerota, A.J. (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 454S 545S. (Pubitemid 351892971)
41. Kenet, G., Kirkham, F., Niederstadt, T., Heinecke, A., Saunders, D., Stoll, M., Brenner, B., Bidlingmaier, C., Heller, C., Knofler, R., Schobess, R., Zieger, B., Sebire, G. Nowak-Gottl, U. (2007) Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurology, 6, 595 603.
42. Kim, J.H., Lee, Y.S., Kim, S.H., Lee, S.K., Lim, M.K. Kim, H.S. (2001) Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology, 219, 645 650.
43. Kitchen, S., Theaker, J. Preston, F.E. (2000) Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay. Blood Coagulation and Fibrinolysis, 11, 137 144.
44. Kuhle, S., Koloshuk, B., Marzinotto, V., Bauman, M., Massicotte, P., Andrew, M., Chan, A., Abdolell, M. Mitchell, L. (2003) A cross-sectional study evaluating post-thrombotic syndrome in children. Thrombosis Research, 111, 227 233.
45. Kuhle, S., Massicotte, P., Dinyari, M., Vegh, P., Mitchell, D., Marzinotto, V., Chan, A., Pieniaszek, H. Mitchell, L.G. (2005) Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events. Thrombosis and Haemostasis, 94, 1164 1171.
46. Kuhle, S., Eulmesekian, P., Kavanagh, B., Massicotte, P., Vegh, P. Mitchell, L.G. (2007a) A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study. Haematologica, 92, 244 247.
47. Kuhle, S., Eulmesekian, P., Kavanagh, B., Massicotte, P., Vegh, P., Lau, A. Mitchell, L.G. (2007b) Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill children. Haematologica, 92, 554 557.
48. Kyrle, P.A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K. Eichinger, S. (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. New England Journal of Medicine, 343, 457 462. (Pubitemid 30646484)
49. Male, C., Foulon, D., Hoogendoorn, H., Vegh, P., Silverman, E., David, M. Mitchell, L. (2005) Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood, 106, 4152 4158.
50. Malowany, J.I., Monagle, P., Knoppert, D.C., Lee, D.S., Wu, J., McCusker, P., Massicotte, M.P., Williams, S. Chan, A.K. & Canadian Paediatric Thrombosis and Hemostasis 2008) Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates. Thrombosis Research, 122, 826 830.
51. Manco-Johnson, M.J. (2006) How I treat venous thrombosis in children. Blood, 107, 21 29.
52. Manco-Johnson, M.J., Nuss, R., Hays, T., Krupski, W., Drose, J. Manco-Johnson, M.L. (2000) Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. Journal of Pediatrics, 136, 446 453.
53. Manco-Johnson, M., Graham, D., Valentino, L. Knapp-Clevenger, R. (2003) Low-molecular-weight heparin dose requirements are age-related through childhood. Journal of Thrombosis and Haemostasis, 1 (Suppl. 1 abstract P1879.
54. Martinelli, I., Mannucci, P.M., De Stefano, V., Taioli, E., Rossi, V., Crosti, F., Paciaroni, K., Leone, G. Faioni, E.M. (1998) Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood, 92, 2353 2358.
55. Massicotte, M.P. (2000) Low-molecular-weight heparin therapy in children. Journal of Pediatric Hematology/Oncology, 22, 98 99.
56. Massicotte, P., Adams, M., Marzinotto, V., Brooker, L.A. Andrew, M. (1996) Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. Journal of Pediatrics, 128, 313 318.
57. Massicotte, M.P., Dix, D., Monagle, P., Adams, M. Andrew, M. (1998a) Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. Journal of Pediatrics, 133, 770 776.
58. Massicotte, P., Leaker, M., Marzinotto, V., Adams, M., Freedom, R., Williams, W., Vegh, P., Berry, L., Shah, B. Andrew, M. (1998b) Enhanced thrombin regulation during warfarin therapy in children compared to adults. Thrombosis and Haemostasis, 80, 570 574.
59. Massicotte, P., Julian, J.A., Gent, M., Shields, K., Marzinotto, V., Szechtman, B., Chan, A.K. Andrew, M. (2003a) An open-label randomised controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thrombosis Research, 109, 101 108.
60. Massicotte, P., Julian, J.A., Marzinotto, V., Gent, M., Shields, K., Chan, A.K., Szechtman, B., Kohne, S., Shepherd, S., Bacher, P. Andrew, M. (2003b) Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patients. Thrombosis Research, 109, 93 99.
61. Massicotte, P., Julian, J.A., Gent, M., Shields, K., Marzinotto, V., Szechtman, B. Andrew, M. (2003c) An open-label randomised controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thrombosis Research, 109, 85 92.
62. Massicotte, M.P., Bauman, M., Black, K. Bajzar, L. (2009) Enoxaparin monitoring: challenges of central line blood samples. Journal of Thrombosis and Haemostasis, 7 (Suppl. 2 Abstract PP-MO-455.
63. McDonald, M.M., Jacobson, L.J., Hay, Jr., W.W. Hathaway, W.E. (1981) Heparin clearance in the newborn. Pediatric Research, 15, 1015 1018.
64. Meissner, M.H., Manzo, R.A., Bergelin, R.O., Markel, A. Strandness, Jr., D.E. (1993) Deep venous insufficiency: the relationship between lysis and subsequent reflux. Journal of Vascular Surgery, 18, 596 605 discussion 606-598.
65. Michaels, L.A., Gurian, M., Hegyi, T. Drachtman, R.A. (2004) Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant. Pediatrics, 114, 703 707.
66. Moharir, M., Shroff, M. MacGregor, D. (2006) Clinical and radiographic features of thrombosis propagation in neonatal and childhood cerebral sinovenous thrombosis. Annals of Neurology, 60 (Suppl. S141.
67. Monagle, P. (2004) Anticoagulation in the young. Heart, 90, 808 812.
68. Monagle, P., Adams, M., Mahoney, M., Ali, K., Barnard, D., Bernstein, M., Brisson, L., David, M., Desai, S., Scully, M.F., Halton, J., Israels, S., Jardine, L., Leaker, M., McCusker, P., Silva, M., Wu, J., Anderson, R., Andrew, M. Massicotte, M.P. (2000) Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatric Research, 47, 763 766.
69. Monagle, P., Michelson, A.D., Bovill, E. Andrew, M. (2001) Antithrombotic therapy in children. Chest, 119, 344S 370S.
70. Monagle, P., Chalmers, E., Chan, A., DeVeber, G., Kirkham, F., Massicotte, P. Michelson, A.D. (2008) Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 887S 968S.
71. Murphy, M.S., John, P.R., Mayer, A.D., Buckels, J.A. Kelly, D.A. (1992) Heparin therapy and bone fractures. Lancet, 340, 1098.
72. Newall, F. Bauman, M. (2006) Point-of-care antithrombotic monitoring in children. Thrombosis Research, 118, 113 121.
73. Newall, F., Barnes, C., Savoia, H., Campbell, J. Monagle, P. (2003a) Warfarin therapy in children who require long-term total parenteral nutrition. Pediatrics, 112, e386.
74. Newall, F., Barnes, C., Ignjatovic, V. Monagle, P. (2003b) Heparin-induced thrombocytopenia in children. Journal of Paediatrics and Child Health, 39, 289 292.
75. Newall, F., Campbell, J. Savioa, H. (2005) Incidence of major bleeding in a large paediatric cohort of patients requiring warfarin therapy. Journal of Thrombosis and Haemostasis 2005 vol 3 supp 1. abstract from ISTH -XX Congress of the International Society on Thrombosis and Haemostasis:OR3057, Sydney.
76. Newall, F., Wallace, T., Crock, C., Campbell, J., Savoia, H., Barnes, C. Monagle, P. (2006a) Venous thromboembolic disease: a single-centre case series study. Journal of Paediatrics and Child Health, 42, 803 807.
77. Newall, F., Monagle, P. Johnston, L. (2006b) Home INR monitoring of oral anticoagulant therapy in children using the CoaguChek S point-of-care monitor and a robust education program. Thrombosis Research, 118, 587 593.
78. Newall, F., Ignjatovic, V., Summerhayes, R., Gan, A., Butt, W., Johnston, L. Monagle, P. (2009a) In vivo age dependency of unfractionated heparin in infants and children. Thrombosis Research, 123, 710 714.
79. Newall, F., Ignjatovic, V., Johnston, L., Lane, G. Monagle, P. (2009b) Do bolus doses of UFH contribute to increased bleeding risks in children? Journal of Thrombosis and Haemostasis, 7 (Suppl. 2 Abstract PP-WE-437.
80. Newall, F., Ignjatovic, V., Johnston, L., Lane, G., Summerhayes, R. Monagle, P. (2009c) Correlation of UFH measures of effect with protamine titration in children. Journal of Thrombosis and Haemostasis, 7 (Suppl. 2 Abstract PP-MO-451.
81. Nohe, N., Flemmer, A., Rumler, R., Praun, M. Auberger, K. (1999) The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. European Journal of Pediatrics, 158 (Suppl. 3 S134 S139.
82. Nowak Gottl, U., K, D., Eldin, N., Yasui, Y., Geissen, C. Mitchell, L. (2009) In pediatric patients, age has more impact on oral anticoagulant dose than VKORC1 or CYP2CP genotypes. Journal of Thrombosis and Haemostasis, 7 (Suppl. 2 Abstract AS-TU-054.
83. Nowak-Gottl, U., Junker, R., Kreuz, W., von Eckardstein, A., Kosch, A., Nohe, N., Schobess, R. Ehrenforth, S. (2001) Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood, 97, 858 862. (Pubitemid 32154265)
84. Nuss, R., Hays, T. Manco-Johnson, M. (1995) Childhood thrombosis. Pediatrics, 96, 291 294.
85. Obaid, L., Byrne, P.J. Cheung, P.Y. (2004) Compartment syndrome in an ELBW infant receiving low-molecular-weight heparins. Journal of Pediatrics, 144, 549.
86. Obladen, M., Ernst, D., Feist, D. Wille, L. (1975) Portal hypertension in children following neonatal umbilical disorders. Journal of Perinatal Medicine, 3, 101 104.
87. O'Brien, S.H., Lee, H. Ritchey, A.K. (2007) Once-daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics study. Journal of Thrombosis and Haemostasis, 5, 1985 1987.
88. van Ommen, C.H., Heijboer, H., Buller, H.R., Hirasing, R.A., Heijmans, H.S. Peters, M. (2001) Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. Journal of Pediatrics, 139, 676 681.
89. van Ommen, C.H., Heijboer, H., van den Dool, E.J., Hutten, B.A. Peters, M. (2003) Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. Journal of Thrombosis and Haemostasis, 1, 2516 2522.
90. Palareti, G., Legnani, C., Cosmi, B., Guazzaloca, G., Pancani, C. Coccheri, S. (2002) Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thrombosis and Haemostasis, 87, 7 12.
91. Palareti, G., Cosmi, B., Legnani, C., Tosetto, A., Brusi, C., Iorio, A., Pengo, V., Ghirarduzzi, A., Pattacini, C., Testa, S., Lensing, A.W. Tripodi, A. (2006) D-dimer testing to determine the duration of anticoagulation therapy. New England Journal of Medicine, 355, 1780 1789.
92. Pengo, V., Lensing, A.W., Prins, M.H., Marchiori, A., Davidson, B.L., Tiozzo, F., Albanese, P., Biasiolo, A., Pegoraro, C., Iliceto, S. Prandoni, P. (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. New England Journal of Medicine, 350, 2257 2264.
93. Prandoni, P., Lensing, A.W., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A.M., Polistena, P., Bernardi, E. Prins, M.H. (1996) The long-term clinical course of acute deep venous thrombosis. Annals of Internal Medicine, 125, 1 7.
94. Punzalan, R.C., Hillery, C.A., Montgomery, R.R., Scott, C.A. Gill, J.C. (2000) Low-molecular-weight heparin in thrombotic disease in children and adolescents. Journal of Pediatric Hematology/Oncology, 22, 137 142.
95. Raffini, L., Huang, Y.S., Witmer, C. Feudtner, C. (2009) Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics, 124, 1001 1008.
96. Revel-Vilk, S. Kenet, G. (2006) Thrombophilia in children with venous thromboembolic disease. Thrombosis Research, 118, 59 65.
97. Revel-Vilk, S., Chan, A., Bauman, M. Massicotte, P. (2003) Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. Journal of Thrombosis and Haemostasis, 1, 915 921.
98. Revel-Vilk, S., Sharathkumar, A., Massicotte, P., Marzinotto, V., Daneman, A., Dix, D. Chan, A. (2004) Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound. Journal of Thrombosis and Haemostasis, 2, 42 46.
99. Risch, L., Huber, A.R. Schmugge, M. (2006) Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thrombosis Research, 118, 123 135.
100. Roy, M., Turner-Gomes, S., Gill, G., Way, C., Mernagh, J. Schmidt, B. (2002) Accuracy of Doppler echocardiography for the diagnosis of thrombosis associated with umbilical venous catheters. Journal of Pediatrics, 140, 131 134.
101. Ruud, E., Holmstrom, H., Hopp, E. Wesenberg, F. (2006a) Central line-associated venous late effects in children without prior history of thrombosis. Acta Paediatrica, 95, 1060 1065.
102. Ruud, E., Holmstrom, H., De Lange, C., Hogstad, E.M. Wesenberg, F. (2006b) Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies - a randomised, controlled study. Acta Paediatrica, 95, 1053 1059.
103. Sanderink, G.J., Le Liboux, A., Jariwala, N., Harding, N., Ozoux, M.L., Shukla, U., Montay, G., Boutouyrie, B. Miro, A. (2002) The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers. Clinical Pharmacology and Therapeutics, 72, 308 318.
104. Sandoval, J.A., Sheehan, M.P., Stonerock, C.E., Shafique, S., Rescorla, F.J. Dalsing, M.C. (2008) Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalised children: an increasing population at risk. Journal of Vascular Surgery, 47, 837 843.
105. Saxon, B.R., Black, M.D., Edgell, D., Noel, D. Leaker, M.T. (1999) Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran). Annals of Thoracic Surgery, 68, 1076 1078.
106. Schmidt, B. Andrew, M. (1995) Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics, 96, 939 943.
107. Schmidt, B., Mitchell, L., Ofosu, F. Andrew, M. (1988) Standard assays underestimate the concentration of heparin in neonatal plasma. Journal of Laboratory and Clinical Medicine, 112, 641 643.
108. Schmugge, M., Risch, L., Huber, A.R., Benn, A. Fischer, J.E. (2002) Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics, 109, E10.
109. Schobess, R., During, C., Bidlingmaier, C., Heinecke, A., Merkel, N. Nowak-Gottl, U. (2006) Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration. Haematologica, 91, 1701 1704.
110. Schuster, J., Meier-Ruge, W. Egli, F. (1969) [Pathology of osteopathy following heparin therapy]. Deutsche Medizinische Wochenschrift, 94, 2334 2338.
111. Sconce, E., Avery, P., Wynne, H. Kamali, F. (2007) Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood, 109, 2419 2423.
112. Shojania, A.M. (2004) More on: is laboratory monitoring of low-molecular-weight heparin necessary? Journal of Thrombosis and Haemostasis, 2, 2276 2277.
113. Simioni, P., Sanson, B.J., Prandoni, P., Tormene, D., Friederich, P.W., Girolami, B., Gavasso, S., Huisman, M.V., Buller, H.R., Wouter ten Cate, J., Girolami, A. Prins, M.H. (1999) Incidence of venous thromboembolism in families with inherited thrombophilia. Thrombosis and Haemostasis, 81, 198 202.
114. Streif, W., Andrew, M., Marzinotto, V., Massicotte, P., Chan, A.K., Julian, J.A. Mitchell, L. (1999) Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood, 94, 3007 3014.
115. Streif, W., Goebel, G., Chan, A.K. Massicotte, M.P. (2003) Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients. Archives of Disease in Childhood Fetal and Neonatal Edition, 88, F365 F370.
116. Tormene, D., Simioni, P., Prandoni, P., Franz, F., Zerbinati, P., Tognin, G. Girolami, A. (2002) The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood, 100, 2403 2405.
117. Tormene, D., Gavasso, S., Rossetto, V. Simioni, P. (2006) Thrombosis and thrombophilia in children: a systematic review. Seminars in Thrombosis and Hemostasis, 32, 724 728.
118. Truitt, A.K., Sorrells, D.L., Halvorson, E., Starring, J., Kurkchubasche, A.G., Tracy, Jr., T.F. Luks, F.I. (2005) Pulmonary embolism: which pediatric trauma patients are at risk? Journal of Pediatric Surgery, 40, 124 127.
119. deVeber, G., Chan, A., Monagle, P., Marzinotto, V., Armstrong, D., Massicotte, P., Leaker, M. Andrew, M. (1998) Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Archives of Neurology, 55, 1533 1537.
120. Vos, L.J., Potocky, V., Broker, F.H., de Vries, J.A., Postma, L. Edens, E. (1974) Splenic vein thrombosis with oesophageal varices: a late complication of umbilical vein catheterization. Annals of Surgery, 180, 152 156.
121. Vossen, C.Y., Conard, J., Fontcuberta, J., Makris, M., FJ, V.D.M., Pabinger, I., Palareti, G., Preston, F.E., Scharrer, I., Souto, J.C., Svensson, P., Walker, I.D. Rosendaal, F.R. (2005) Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). Journal of Thrombosis and Haemostasis, 3, 459 464.
122. Warkentin, T.E., Greinacher, A., Koster, A. Lincoff, A.M. (2008) Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 340S 380S.
123. Welke, K.F., Shen, I. Ungerleider, R.M. (2006) Current assessment of mortality rates in congenital cardiac surgery. Annals of Thoracic Surgery, 82, 164 170 discussion 170-161.
124. White, R.H. (2003) The epidemiology of venous thromboembolism. Circulation, 107, I4 I8.
125. Young, G. Boshkov, L. (2007) Prospective study of direct thrombin inhibition with argatroban in pediatric patients requiring nonheparinanticoagulation. Blood (ASH meeting Abstracts), 110, Abstracts 553.
126. Young, L., Ockelford, P., Milne, D., Rolfe-Vyson, V., McKelvie, S. Harper, P. (2006) Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality. Journal of Thrombosis and Haemostasis, 4, 1919 1924.
127. Young, G., Tarantino, M.D., Wohrley, J., Weber, L.C., Belvedere, M. Nugent, D.J. (2007) Pilot dose-finding and safety study of bivalirudin in infants <6 months of age with thrombosis. Journal of Thrombosis and Haemostasis, 5, 1654 1659.
128. Young, G., Albisetti, M., Bonduel, M., Brandao, L., Chan, A., Friedrichs, F., Goldenberg, N.A., Grabowski, E., Heller, C., Journeycake, J., Kenet, G., Krumpel, A., Kurnik, K., Lubetsky, A., Male, C., Manco-Johnson, M., Mathew, P., Monagle, P., van Ommen, H., Simioni, P., Svirin, P., Tormene, D. Nowak-Gottl, U. (2008) Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation, 118, 1373 1382.